450
Participants
Start Date
April 9, 2021
Primary Completion Date
April 12, 2024
Study Completion Date
August 8, 2024
Candesartan Oral Tablet 8 mg
1 over-encapsulated tablet once daily, containing candesartan 8 mg, for 12 weeks (84 days).
Candesartan Oral Tablet 16 mg
1 over-encapsulated tablet once daily, containing candesartan 16 mg, for 12 weeks (84 days).
Placebo oral tablet
1 over-encapsulated tablet once daily, containing placebo, for 12 weeks (84 days).
Tartu University Clinics, Tartu
Haukeland University Hospital, Bergen
Nordland Hospital, Bodø
Sørlandet Hospital, Kristiansand
Akershus University Hospital AHUS, Lørenskog
Møre and Romsdal Hospital Molde, Molde
Rikshospitalet University Hospital, Oslo
Ullevål University Hospital, Oslo
University Hospital of North Norway, Tromsø
St Olavs Hospital, Trondheim
Norwegian University of Science and Technology
OTHER
Nordlandssykehuset HF
OTHER
Molde Hospital
OTHER
Haukeland University Hospital
OTHER
Sorlandet Hospital HF
OTHER_GOV
University Hospital, Akershus
OTHER
Ullevaal University Hospital
OTHER
Rikshospitalet University Hospital
OTHER
University Hospital of North Norway
OTHER
Tartu University Hospital
OTHER
St. Olavs Hospital
OTHER